Elagolix Curbs Heavy Bleeding Linked to Uterine Leiomyomas Elagolix Curbs Heavy Bleeding Linked to Uterine Leiomyomas
Elagolix sodium, an oral short-acting nonpeptide gonadotropin-releasing hormone antagonist has been approved by the FDA at a dose of 300 mg twice daily with add-back therapy for up to 24 months.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 8, 2023 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Source Type: news
Mayo Clinic Q and A: What are fibroids?
DEAR MAYO CLINIC: I am 27 and have heavy menstrual cycles. In the past year, I have begun to have more pelvic pain, especially during my period. A friend said I should get checked for fibroids. What are fibroids, and how do you treat them? ANSWER: Uterine fibroids, also called leiomyomas or myomas, are benign masses that come from the muscle portion of the uterus. Fibroids are common. Approximately 80% of people born with a uterus will… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - May 25, 2022 Category: Databases & Libraries Source Type: news
ED Visits for Leiomyomas Increased From 2006 to 2017
FRIDAY, June 11, 2021 -- From 2006 to 2017, there was an increase in the number of emergency department visits for leiomyomas, but the admission rate for these visits decreased, according to a study published in the May issue of Obstetrics&... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 11, 2021 Category: Pharmaceuticals Source Type: news
Women's Wellness: Uterine fibroids are common noncancerous growths
Uterine fibroids are noncancerous growths of the uterus that often appear during childbearing years. Also called leiomyomas (lie-o-my-O-muhs) or myomas, uterine fibroids aren't associated with an increased risk of uterine cancer and almost never develop into cancer. Fibroids range in size from seedlings, undetectable by the human eye, to bulky masses that can distort and [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - October 16, 2020 Category: Research Source Type: news
Uterine artery embolization can be considered for well controlled symptomatic leiomyomas
(American Roentgen Ray Society) A new study published in the April 2019 issue of the American Journal of Roentgenology (AJR) investigates the safety of uterine artery embolization (UAE) for symptomatic leiomyomas in patients with various autoimmune diseases. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 29, 2019 Category: International Medicine & Public Health Source Type: news
Positive seatbelt sign with avulsed leiomyoma following motor vehicle accident leading to hemoperitoneum - Manoukian MAC, Tembhekar AR, Medeiros SE.
In this report, we describe a 29-year-old nulligra... (Source: SafetyLit)
Source: SafetyLit - September 21, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Uterine-fibroid Risk Higher in Women With Central Centrifugal Cicatricial Alopecia Uterine-fibroid Risk Higher in Women With Central Centrifugal Cicatricial Alopecia
Black women with central centrifugal cicatricial alopecia (CCCA) are at increased risk for developing uterine leiomyomas (ULs), according to a retrospective study.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - January 8, 2018 Category: Pathology Tags: Pathology & Lab Medicine News Source Type: news
Study shows increased risk of uterine fibroids in African-American women with a common form of hair
(Johns Hopkins Medicine) In a study of medical records gathered on hundreds of thousands of African-American women, Johns Hopkins researchers say they have evidence that women with a common form of hair loss have an increased chance of developing uterine leiomyomas, or fibroids (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 28, 2017 Category: International Medicine & Public Health Source Type: news
Uterine-Sparing Procedures for Leiomyomas Have Trade-offs Uterine-Sparing Procedures for Leiomyomas Have Trade-offs
Uterine-sparing procedures for uterine leiomyomas had small but significant differences in risks for reintervention, subsequent hysterectomy, and subsequent complications, a study found.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 11, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news
Fibroids 101
Fibroids are a common gynecological diagnosis, often misrepresented yet rarely ignored.
Fibroids (also known as myomas or leiomyoma) are benign (non-cancerous) growths in the uterus (womb). They can be attached to the wall of the uterus by a stalk, may grow into the wall of the uterus, jut out into the cavity of the uterus or appear on the outside of the uterus.
Growth of fibroids fluctuates with hormone levels. Unfortunately, no one really knows what will cause a fibroid to grow or shrink in a particular person so much of the scientific information is just dogma.
Studies have shown that estrogen makes fibroids grow, t...
Source: Healthy Living - The Huffington Post - June 23, 2016 Category: Consumer Health News Source Type: news
Botulinum Toxin Helpful in Painful Cutaneous LeiomyomasBotulinum Toxin Helpful in Painful Cutaneous Leiomyomas
Botulinum toxin A may improve skin-related quality of life in patients with cutaneous leiomyomas, according to Maryland-based researchers. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 11, 2015 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Botox Fails to Reduce Pain in Skin Leiomyomas (CME/CE)
(MedPage Today) -- But significant improvements seen in quality-of-life scores (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - August 6, 2015 Category: Dermatology Source Type: news
Uterine fibroids: a clinical update
Fibroids (leiomyoma) are non-cancerous tumors of the uterine muscle found in up to 80% of premenopausal women. There are a range of hormonal treatments available to lessen the symptoms associated with fibroids and several surgical options to remove fibroids.
Hide related content:
Show related content
Featured In Issue:
Nursing in Practice | 84
read more (Source: Nursing in Practice)
Source: Nursing in Practice - May 20, 2015 Category: Nursing Authors: Kerrie Schofield Tags: Women ' s health Source Type: news
More Nonsurgical Options for Fibroids Becoming AvailableMore Nonsurgical Options for Fibroids Becoming Available
Dr Peter Kovacs summarizes the latest options for leiomyomas. Medscape Ob/Gyn (Source: Medscape ObGyn and Womens Health Headlines)
Source: Medscape ObGyn and Womens Health Headlines - December 2, 2014 Category: OBGYN Tags: Ob/Gyn & Women ' s Health Viewpoint Source Type: news
Radiological Case: Intravenous LeiomyomatosisRadiological Case: Intravenous Leiomyomatosis
This case study documents a patient with intravenous leiomyomatosis, a rare neoplasm thought to be due to growth of a uterine leiomyoma within or into the intima of pelvic veins. Applied Radiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 28, 2014 Category: Consumer Health News Tags: Radiology Journal Article Source Type: news
